These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 19418394)

  • 21. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
    Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus.
    Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A
    Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
    Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
    Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent clonal areas and clonal expansion in Barrett's esophagus.
    Raskind WH; Norwood T; Levine DS; Haggitt RC; Rabinovitch PS; Reid BJ
    Cancer Res; 1992 May; 52(10):2946-50. PubMed ID: 1581911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
    Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
    Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus.
    Wolfsen HC; Crook JE; Krishna M; Achem SR; Devault KR; Bouras EP; Loeb DS; Stark ME; Woodward TA; Hemminger LL; Cayer FK; Wallace MB
    Gastroenterology; 2008 Jul; 135(1):24-31. PubMed ID: 18442484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.
    Fang M; Lew E; Klein M; Sebo T; Su Y; Goyal R
    Am J Gastroenterol; 2004 Oct; 99(10):1887-94. PubMed ID: 15447746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports.
    Curvers WL; Peters FP; Elzer B; Schaap AJ; Baak LC; van Oijen A; Mallant-Hent RM; Ten Kate F; Krishnadath KK; Bergman JJ
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):601-7. PubMed ID: 18679060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
    Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
    Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus.
    Lim CH; Rotimi O; Dexter SP; Axon AT
    Gastrointest Endosc; 2006 Aug; 64(2):195-9. PubMed ID: 16860068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images with histology.
    Chen Y; Aguirre AD; Hsiung PL; Desai S; Herz PR; Pedrosa M; Huang Q; Figueiredo M; Huang SW; Koski A; Schmitt JM; Fujimoto JG; Mashimo H
    Endoscopy; 2007 Jul; 39(7):599-605. PubMed ID: 17611914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol.
    Kariv R; Plesec TP; Goldblum JR; Bronner M; Oldenburgh M; Rice TW; Falk GW
    Clin Gastroenterol Hepatol; 2009 Jun; 7(6):653-8; quiz 606. PubMed ID: 19264576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus.
    Bajbouj M; Vieth M; Rösch T; Miehlke S; Becker V; Anders M; Pohl H; Madisch A; Schuster T; Schmid RM; Meining A
    Endoscopy; 2010 Jun; 42(6):435-40. PubMed ID: 20506064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetic acid allows effective selection of areas for obtaining biopsy samples in Barrett's esophagus.
    Vázquez-Iglesias JL; Alonso-Aguirre P; Diz-Lois MT; Vázquez-Millán MA; Alvarez A; Lorenzo MJ
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):187-93. PubMed ID: 17301644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and clinical significance of the AgNOR and PCNA in Barrett's adenocarcinoma and its precancerous lesions].
    Li H; Yao S; Stuart R
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):286-8. PubMed ID: 7587897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.